You are here

Article Text

Article menu
Download PDFPDF
Treatment
Aspirin but not vitamin E prevented cardiovascular events in patients at risk

https://doi.org/10.1136/ebn.4.3.86

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Collaborative Group of the Primary Prevention Project (PPP).Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice.Lancet2001 Jan 13;357:89–95OpenUrlCrossRefPubMedWeb of Science

    QUESTION: In patients with ≥1 cardiovascular risk factor but no history of cardiovascular disease, do aspirin and vitamin E prevent cardiovascular events?

    Design

    Randomised (allocation concealed), unblinded, 2 × 2 factorial trial with a mean follow up of 3.6 years.

    Setting

    315 general practices and 15 hospital hypertension units in Italy.

    Patients

    4495 patients (mean age 64 y, 58% women) aged ≥50 years who had ≥1 major cardiovascular risk factor: age ≥65 years, hypertension, hypercholesterolaemia, diabetes mellitus, obesity, and family history of myocardial infarction (MI) before 55 years of age in ≥1 parent or sibling. Exclusion criteria were treatment with antiplatelet drugs, chronic use of anti-inflammatory agents or anticoagulants, contraindication …

    View Full Text

    Footnotes

    • Sources of funding: Medical Department of Bayer, Italy; aspirin preparation supplied by Bayer; vitamin E capsules supplied by Bracco SpA.

    • For correspondence: Dr M C Roncaglioni, Istituto di Ricerche Farmacologiche “Mario Negri,” Via Eritrea 62, 20157 Milan, Italy. Fax +39 02 39001916.

    • A modified version of this abstract also appears in Evidence–Based Medicine.